Prevalence and clinical impact of left atrial thrombus and dense spontaneous echo contrast in patients with atrial fibrillation and low CHADS2 score
Kleemann et al.
Eur J Echocardiogr 2008;0:jen256v1-6.
ABSTRACT
| FULL TEXT
Racial/Ethnic Differences in Ischemic Stroke Rates and the Efficacy of Warfarin Among Patients With Atrial Fibrillation
Shen et al.
Stroke 2008;39:2736-2743.
ABSTRACT
| FULL TEXT
Atrial fibrillation is associated with impaired cognitive function and hippocampal atrophy: silent cerebral ischaemia vs. Alzheimer's disease?
Goette and Braun-Dullaeus
Eur Heart J 2008;29:2067-2069.
FULL TEXT
Stroke risk in the elderly: it's not all about visible clot
Kanagaratnam
Heart 2008;94:1109-1110.
FULL TEXT
Alternatives to warfarin in atrial fibrillation: drugs and devices
Bayard et al.
Heart 2008;94:1113-1116.
FULL TEXT
Soluble CD40 Ligand, Platelet Surface CD40 Ligand, and Total Platelet CD40 Ligand in Atrial Fibrillation: Relationship to Soluble P-Selectin, Stroke Risk Factors, and Risk Factor Intervention
Choudhury et al.
Chest 2008;134:574-581.
ABSTRACT
| FULL TEXT
Increased Major Bleeding Complications Related to Triple Antithrombotic Therapy Usage in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Artery Stenting
Manzano-Fernandez et al.
Chest 2008;134:559-567.
ABSTRACT
| FULL TEXT
Guidelines for the management of anticoagulant and antiplatelet therapy in patients undergoing endoscopic procedures
Veitch et al.
Gut 2008;57:1322-1329.
FULL TEXT
Prevention of stroke in patients with atrial fibrillation: current strategies and future directions
Hohnloser et al.
Eur Heart J Suppl 2008;10:H4-H10.
ABSTRACT
| FULL TEXT
Atrial fibrillation management by practice cardiologists: a prospective survey on the adherence to guidelines in the real world
Meiltz et al.
Europace 2008;10:674-680.
ABSTRACT
| FULL TEXT
The Perioperative Management of Antithrombotic Therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Douketis et al.
Chest 2008;133:299S-339S.
ABSTRACT
| FULL TEXT
Antithrombotic Therapy in Atrial Fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Singer et al.
Chest 2008;133:546S-592S.
ABSTRACT
| FULL TEXT
Comparison of 12 Risk Stratification Schemes to Predict Stroke in Patients With Nonvalvular Atrial Fibrillation
Stroke Risk in Atrial Fibrillation Working Group
Stroke 2008;39:1901-1910.
ABSTRACT
| FULL TEXT
Risks and Benefits of Oral Anticoagulation Compared With Clopidogrel Plus Aspirin in Patients With Atrial Fibrillation According to Stroke Risk: The Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE-W)
Healey et al.
Stroke 2008;39:1482-1486.
ABSTRACT
| FULL TEXT
Catheter ablation for atrial fibrillation
Lubitz et al.
BMJ 2008;336:819-826.
FULL TEXT
Safety of percutaneous coronary intervention during uninterrupted oral anticoagulant treatment
Karjalainen et al.
Eur Heart J 2008;29:1001-1010.
ABSTRACT
| FULL TEXT
Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation?
Nieuwlaat et al.
Eur Heart J 2008;29:915-922.
ABSTRACT
| FULL TEXT
Atrial fibrillation subtypes, risk of stroke, and antithrombotic therapy
Stramba-Badiale
Eur Heart J 2008;29:840-842.
FULL TEXT
Use of Anticoagulation in Elderly Patients with Atrial Fibrillation Who Are at Risk for Falls
Garwood and Corbett
The Annals of Pharmacotherapy 2008;42:523-532.
ABSTRACT
| FULL TEXT
Cardiogenic and aortogenic brain embolism.
Doufekias et al.
J Am Coll Cardiol 2008;51:1049-1059.
ABSTRACT
| FULL TEXT
An update on cardioembolic stroke
Weir
Postgrad. Med. J. 2008;84:133-142.
ABSTRACT
| FULL TEXT
Comparison of Risk Stratification Schemes to Predict Thromboembolism in People With Nonvalvular Atrial Fibrillation
Fang et al.
J Am Coll Cardiol 2008;51:810-815.
ABSTRACT
| FULL TEXT
Anticoagulant and Antiplatelet Therapy Use in 426 Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention and Stent Implantation: Implications for Bleeding Risk and Prognosis
Ruiz-Nodar et al.
J Am Coll Cardiol 2008;51:818-825.
ABSTRACT
| FULL TEXT
ACC/AHA/Physician Consortium 2008 Clinical Performance Measures for Adults With Nonvalvular Atrial Fibrillation or Atrial Flutter: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and the Physician Consortium for Performance Improvement (Writing Committee to Develop Clinical Performance Measures for Atrial Fibrillation) Developed in Collaboration With the Heart Rhythm Society
Estes et al.
J Am Coll Cardiol 2008;51:865-884.
FULL TEXT
ACC/AHA/Physician Consortium 2008 Clinical Performance Measures for Adults With Nonvalvular Atrial Fibrillation or Atrial Flutter: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and the Physician Consortium for Performance Improvement (Writing Committee to Develop Clinical Performance Measures for Atrial Fibrillation)
Estes et al.
Circulation 2008;117:1101-1120.
FULL TEXT
Prognostic value of plasma soluble CD40 ligand in patients with chronic non-valvular atrial fibrillation
Duygu et al.
Europace 2008;10:210-214.
ABSTRACT
| FULL TEXT
Highlights of the year in JACC 2007.
DeMaria et al.
J Am Coll Cardiol 2008;51:490-512.
FULL TEXT
Risk of Thromboembolism With Short-term Interruption of Warfarin Therapy
Garcia et al.
Arch Intern Med 2008;168:63-69.
ABSTRACT
| FULL TEXT
Catheter Ablation Therapy for Supraventricular Arrhythmias
Marine
JAMA 2007;298:2768-2778.
ABSTRACT
| FULL TEXT
Warfarin reduced major stroke more than aspirin in elderly patients with atrial fibrillation in primary care.
Jaffer
Evid. Based Med. 2007;12:172-172.
FULL TEXT
Atrial fibrillation in the 'real world': undecided issues
Nieuwlaat et al.
Eur Heart J Suppl 2007;9:I122-I128.
ABSTRACT
| FULL TEXT
Improving anticoagulation management in patients with atrial fibrillation
Dager
Am J Health Syst Pharm 2007;64:2279-2280.
FULL TEXT
ASHP Therapeutic Position Statement on Antithrombotic Therapy in Chronic Atrial Fibrillation
Nutescu
Am J Health Syst Pharm 2007;64:2281-2291.
FULL TEXT
Increased mortality in paroxysmal atrial fibrillation: report from the Stockholm Cohort-Study of Atrial Fibrillation (SCAF)
Friberg et al.
Eur Heart J 2007;28:2346-2353.
ABSTRACT
| FULL TEXT
Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review
Hughes et al.
QJM 2007;100:599-607.
ABSTRACT
| FULL TEXT
Comment on the WASPO study
Dudley and Fuller
Age Ageing 2007;36:598-599.
FULL TEXT
Can Patients at Elevated Risk of Stroke Treated With Anticoagulants Be Further Risk Stratified?
Baruch et al.
Stroke 2007;38:2459-2463.
ABSTRACT
| FULL TEXT
Independent predictors of stroke in patients with atrial fibrillation: A systematic review
The Stroke Risk in Atrial Fibrillation Working Gro
Neurology 2007;69:546-554.
ABSTRACT
| FULL TEXT
A Cautionary Note on Data Sources for Evidence-Based Clinical Decisions: Warfarin and Stroke Prevention
Thomson et al.
Med Decis Making 2007;27:438-447.
ABSTRACT
Racial/Ethnic Differences in the Risk of Intracranial Hemorrhage Among Patients With Atrial Fibrillation
Shen et al.
J Am Coll Cardiol 2007;50:309-315.
ABSTRACT
| FULL TEXT
HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation Developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and Approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society.
Calkins et al.
Europace 2007;9:335-379.
FULL TEXT
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
Authors/Task Force Members et al.
Eur Heart J Suppl 2007;9:C3-C74.
FULL TEXT
Bleeding While Starting Anticoagulation for Thromboembolism Prophylaxis in Elderly Patients With Atrial Fibrillation: From Bad to Worse
Wyse
Circulation 2007;115:2684-2686.
FULL TEXT
Major Hemorrhage and Tolerability of Warfarin in the First Year of Therapy Among Elderly Patients With Atrial Fibrillation
Hylek et al.
Circulation 2007;115:2689-2696.
ABSTRACT
| FULL TEXT
Platelet Surface CD62P and CD63, Mean Platelet Volume, and Soluble/Platelet P-Selectin as Indexes of Platelet Function in Atrial Fibrillation: A Comparison of "Healthy Control Subjects" and "Disease Control Subjects" in Sinus Rhythm
Choudhury et al.
J Am Coll Cardiol 2007;49:1957-1964.
ABSTRACT
| FULL TEXT
'Rules of thumb' or reflective practice? Understanding senior physicians' decision-making about anti-thrombotic usage in atrial fibrillation
Anderson et al.
QJM 2007;100:263-269.
ABSTRACT
| FULL TEXT
Watching the Watchman
Block
J Am Coll Cardiol 2007;49:1496-1497.
FULL TEXT
Initial Worldwide Experience With the WATCHMAN Left Atrial Appendage System for Stroke Prevention in Atrial Fibrillation
Sick et al.
J Am Coll Cardiol 2007;49:1490-1495.
ABSTRACT
| FULL TEXT
Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting
Karjalainen et al.
Eur Heart J 2007;28:726-732.
ABSTRACT
| FULL TEXT
Enhanced cardiovascular morbidity and mortality during rhythm control treatment in persistent atrial fibrillation in hypertensives: data of the RACE study
Rienstra et al.
Eur Heart J 2007;28:741-751.
ABSTRACT
| FULL TEXT
Effect of hypertension on anticoagulated patients with atrial fibrillation
Lip et al.
Eur Heart J 2007;28:752-759.
ABSTRACT
| FULL TEXT
Gender-Related Differences in Presentation, Treatment, and Outcome of Patients With Atrial Fibrillation in Europe: A Report From the Euro Heart Survey on Atrial Fibrillation
Dagres et al.
J Am Coll Cardiol 2007;49:572-577.
ABSTRACT
| FULL TEXT
Multifaceted implementation of stroke prevention guidelines in primary care: cluster-randomised evaluation of clinical and cost effectiveness
Wright et al.
Qual Saf Health Care 2007;16:51-59.
ABSTRACT
| FULL TEXT
Combined Aspirin-Oral Anticoagulant Therapy Compared With Oral Anticoagulant Therapy Alone Among Patients at Risk for Cardiovascular Disease: A Meta-analysis of Randomized Trials
Dentali et al.
Arch Intern Med 2007;167:117-124.
ABSTRACT
| FULL TEXT
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
Authors/Task Force Members et al.
Eur Heart J 2007;28:88-136.
FULL TEXT
The impact of long-term warfarin on the quality of life of elderly people with atrial fibrillation
Das et al.
Age Ageing 2007;36:95-97.
FULL TEXT
Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation
Nieuwlaat et al.
Eur Heart J 2006;27:3018-3026.
ABSTRACT
| FULL TEXT
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Writing Committee Members et al.
Europace 2006;8:651-745.
FULL TEXT
Additive Role of Plasma von Willebrand Factor Levels to Clinical Factors for Risk Stratification of Patients With Atrial Fibrillation
Lip et al.
Stroke 2006;37:2294-2300.
ABSTRACT
| FULL TEXT
Risk of Thromboembolic Events After Percutaneous Left Atrial Radiofrequency Ablation of Atrial Fibrillation
Oral et al.
Circulation 2006;114:759-765.
ABSTRACT
| FULL TEXT
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Fuster et al.
J Am Coll Cardiol 2006;48:854-906.
FULL TEXT
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Fuster et al.
J Am Coll Cardiol 2006;48:e149-e246.
FULL TEXT
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Fuster et al.
Circulation 2006;114:e257-e354.
FULL TEXT
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Fuster et al.
Circulation 2006;114:700-752.
FULL TEXT
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation executive summary: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Authors/Task Force Members et al.
Eur Heart J 2006;27:1979-2030.
FULL TEXT
Stroke prophylaxis in atrial fibrillation: who gets it and who does not?: Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study)
Friberg et al.
Eur Heart J 2006;27:1954-1964.
ABSTRACT
| FULL TEXT
Evaluation of a novel device for left atrial appendage exclusion: The second-generation atrial exclusion device.
Kamohara et al.
J. Thorac. Cardiovasc. Surg. 2006;132:340-346.
ABSTRACT
| FULL TEXT
Trends in the prevalence of diagnosed atrial fibrillation, its treatment with anticoagulation and predictors of such treatment in UK primary care
DeWilde et al.
Heart 2006;92:1064-1070.
ABSTRACT
| FULL TEXT
Atrial Fibrillation and Stroke in the General Medicare Population: A 10-Year Perspective (1992 to 2002)
Lakshminarayan et al.
Stroke 2006;37:1969-1974.
ABSTRACT
| FULL TEXT
Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline.
Goldstein et al.
Circulation 2006;113:e873-e923.
ABSTRACT
| FULL TEXT
Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline.
Goldstein et al.
Stroke 2006;37:1583-1633.
ABSTRACT
| FULL TEXT
Warfarin Exposure and the Risk of Thromboembolic and Major Bleeding Events Among Medicaid Patients with Atrial Fibrillation
Boulanger et al.
The Annals of Pharmacotherapy 2006;40:1024-1029.
ABSTRACT
| FULL TEXT
Not All Patients With Atrial Fibrillation-Associated Ischemic Stroke Can Be Started on Anticoagulant Therapy
Somerfield et al.
Stroke 2006;37:1217-1220.
ABSTRACT
| FULL TEXT
Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology
Stramba-Badiale et al.
Eur Heart J 2006;27:994-1005.
ABSTRACT
| FULL TEXT
Use and Effectiveness of Warfarin in Medicare Beneficiaries With Atrial Fibrillation
Birman-Deych et al.
Stroke 2006;37:1070-1074.
ABSTRACT
| FULL TEXT
Translating the Results of Randomized Trials into Clinical Practice: The Challenge of Warfarin Candidacy Among Hospitalized Elderly Patients With Atrial Fibrillation
Hylek et al.
Stroke 2006;37:1075-1080.
ABSTRACT
| FULL TEXT
Translating Clinical Research into Clinical Practice: Impact of Using Prediction Rules To Make Decisions
Reilly and Evans
ANN INTERN MED 2006;144:201-209.
ABSTRACT
| FULL TEXT
Barriers to using warfarin in non-valvular atrial fibrillation.
Gattellari et al.
BMJ 2006;332:303-304.
FULL TEXT
A novel device for left atrial appendage exclusion
Kamohara et al.
J. Thorac. Cardiovasc. Surg. 2005;130:1639-1644.
ABSTRACT
| FULL TEXT
Gender Differences in the Risk of Ischemic Stroke and Peripheral Embolism in Atrial Fibrillation: The AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) Study
Fang et al.
Circulation 2005;112:1687-1691.
ABSTRACT
| FULL TEXT
Preference-Based Antithrombotic Therapy in Atrial Fibrillation: Implications for Clinical Decision Making
Man-Son-Hing et al.
Med Decis Making 2005;25:548-559.
ABSTRACT
